Laser-based breast imaging developer Imaging Diagnostic Systems has signed a collaboration agreement with Schering of Berlin. The two firms will evaluate the use of fluorescent dyes developed by Schering for potential application in detecting breast cancer, according to Fort Lauderdale, FL-based Imaging Diagnostic.
Imaging Diagnostic’s CT laser mammography technology is based on the penetration of near-infrared light into tissue. Schering’s fluorescent contrast agent would accumulate in lesions like breast tumors. Use of the contrast agent could potentially improve the sensitivity and specificity of unenhanced optical mammography by providing a unique signal that could be detected by the system.
By AuntMinnie.com staff writersMarch 26, 2002
Related Reading
IMDS president quits, March 18, 2002
IMDS lands two European installs, February 7, 2002
IMDS signs on European distributor, February 4, 2002
Imaging Diagnostic gets IDE install, November 19, 2001
Imaging Diagnostic Systems gets Mexican install, October 10, 2001
Copyright © 2002 AuntMinnie.com
